Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Anthony Digiandomenico is Director at Mdb Capital Holdings, LLC. OQRO lists 31 transactions filed with the SEC under this name, the latest on Oct 19, 2026, each linked to the official Form 4.
Director
Disclosures on record
31
Companies involved
4
12 buys, median −20.7 pts vs S&P 500, beat it 2 of 12 times.
Average −16.6 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Dec 20, 2024 to Aug 8, 2025, measured from the first close after the filing. Past results, not a forecast.
12 purchases disclosed; 17% of the 12 measured at 90 days finished ahead of the index.
Rank 72 of the 82 insiders with at least 10 purchases measured at 90 days. The middle of that group is −5.5 pts (median, against the S&P 500).
ExozymesEXOZ
Oct 1, 202610Kdisclosed Oct 19
DetailsOfficial recordClearsign TechnologiesCLIR
3 disclosures · Apr 2026 – Oct 2026
Equal weight counts every purchase once; by size counts it for its disclosed dollars. Both are measured from the first close after it was reported. Past results describe the past, not a forecast. How this is measured · Leaderboard
Sep 30, 20263,766disclosed Oct 2
Jun 30, 20264,595disclosed Jul 2
DetailsOfficial recordMar 31, 20263,024disclosed Apr 2
DetailsOfficial recordJan 21, 202660Kdisclosed Jan 24
DetailsOfficial recordMdb Capital Holdings, LLCMDBH
26 disclosures · Dec 2024 – Aug 2025 · 26 bought
Apr 7, 2025Bought~$7Kdisclosed Aug 8
DetailsOfficial recordFeb 13, 2025Bought~$5.8Kdisclosed Feb 15
DetailsOfficial recordFeb 12, 2025Bought~$1.8Kdisclosed Feb 15
DetailsOfficial recordFeb 11, 2025Bought~$6.2K
DetailsOfficial recordFeb 7, 2025Bought~$6.2Kdisclosed Feb 11
DetailsOfficial recordFeb 4, 2025Bought~$2.5Kdisclosed Feb 6
DetailsOfficial recordFeb 5, 2025Bought~$1.9Kdisclosed Feb 6
DetailsOfficial recordFeb 3, 2025Bought~$6.2K
DetailsOfficial recordJan 31, 2025Bought~$6.2Kdisclosed Feb 3
DetailsOfficial recordJan 30, 2025Bought~$622disclosed Feb 3
DetailsOfficial recordJan 27, 2025Bought~$5.8Kdisclosed Jan 29
DetailsOfficial recordJan 29, 2025Bought~$87
DetailsOfficial recordJan 22, 2025Bought~$5.8Kdisclosed Jan 27
DetailsOfficial recordJan 24, 2025Bought~$1Kdisclosed Jan 27
DetailsOfficial recordJan 23, 2025Bought~$1.2Kdisclosed Jan 27
DetailsOfficial recordJan 21, 2025Bought~$6.2Kdisclosed Jan 22
DetailsOfficial recordJan 17, 2025Bought~$6.1Kdisclosed Jan 22
DetailsOfficial recordJan 16, 2025Bought~$5.6Kdisclosed Jan 22
DetailsOfficial recordJan 15, 2025Bought~$6K
DetailsOfficial recordJan 13, 2025Bought~$6.2Kdisclosed Jan 15
DetailsOfficial recordJan 14, 2025Bought~$6.2Kdisclosed Jan 15
DetailsOfficial recordJan 3, 2025Bought~$100disclosed Jan 8
DetailsOfficial recordDec 20, 2024Bought~$2.2Kdisclosed Dec 30
DetailsOfficial recordDec 17, 2024Bought~$11Kdisclosed Dec 20
DetailsOfficial recordDec 18, 2024Bought~$6.2Kdisclosed Dec 20
DetailsOfficial recordDec 19, 2024Bought~$6.2Kdisclosed Dec 20
DetailsOfficial recordAs of the latest filing on , Anthony Digiandomenico reported holding 136,589 shares of Endra Life Sciences (NDRA), worth about $602K at the last close of $4 (Nov 13, 2026). Holdings are also on file at Mdb Capital Holdings, LLC (MDBH); together they are worth about $746K.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Endra Life Sciences NDRA | 136,589 | 137K direct | $4 | $602K | Jan 21, 2026 |
| Mdb Capital Holdings, LLC MDBH | 95,699 | 96K direct | $2 | $144K | Apr 7, 2025 |
Is this Anthony Digiandomenico’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Anthony Digiandomenico bought shares on the open market in 2018, 2020, 2023, 2024 and 2025 across 3 companies.
Anthony Digiandomenico reported 35 open-market purchases and 0 sales since 2018; purchases in 5 different years, most recently 2025.
| Year | Bought | Sold |
|---|---|---|
| 2025 | $95K22×22 trades | — |
| 2024 | $25K4×4 trades | — |
| 2023 | $100K1×1 trade | — |
| 2020 | $17K3×3 trades | — |
| 2018 | $276K5×5 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Jan 21, 2026, Anthony Digiandomenico reported holding 136,589 shares of Endra Life Sciences (NDRA). At the last close of $4 on Nov 13, 2026, that is about $602K. This is the stake disclosed in filings, not a net worth.
Anthony Digiandomenico bought shares on the open market in 2018, 2020, 2023, 2024 and 2025 across 3 companies.
In SEC filings since 2018: the latest open-market purchase is from 2025; no open-market sale is on record.
3 companies: Mdb Capital Holdings, LLC (MDBH, 2024–2025), Endra Life Sciences (NDRA, 2020–2023), Cue Biopharma (CUE, 2018).
Anthony Digiandomenico reported 26 open-market purchases and 0 sales here, 2024 to 2025.
Anthony Digiandomenico reported 5 open-market purchases and 0 sales here, 2018.
Anthony Digiandomenico reported 4 open-market purchases and 0 sales here, 2020 to 2023.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
